Zirtek Plus – Decongestant
Zirtek Plus Decongestant 5mg/120mg prolonged release tablets contains two active substances: cetirizine dihydrochloride which is an antihistamine and pseudoephedrine hydrochloride which is a decongestant.
Zirtek Plus Decongestant is a medicine that is used to relieve allergic symptoms, especially when the anti-allergy properties of cetirizine are combined with the effects of pseudoephedrine in reducing swelling of the mucous membranes inside the nose.
Zirtek Plus Decongestant is indicated for the treatment of symptoms such as blocked nose, sneezing, runny nose, itchy nose or itchy eyes, which occur in seasonal allergic rhinitis (hay fever) or perennial allergic rhinitis (house-dust allergy).
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Adults: 1 tablet twice daily (one in the morning and one in the evening).
Adolescents from 12 years of age and above: 1 tablet twice daily (one in the morning and one in the evening).
Zirtek Plus Decongestant is contraindicated for children younger than 12 years.
If you suffer from kidney or liver disease, please inform your doctor or pharmacist, who may adjust your dose.
Method of administration and duration of treatment:
Oral use. The tablet must be swallowed whole with a some liquid with or without food and must not be broken, crunched or chewed.
After the allergy-induced symptoms have been relieved, it is often recommended that treatment is continued in the pollen season with a medication that contains only an anti-allergy substance.
If symptoms have not subsided after 7 days, ask your doctor for advice.
Warning - Do not exceed stated dose
Hazards and Cautions:
Consult your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, complementary therapies or if you have a medical condition. This medicine may not be suitable for you if you have a medical condition or taking any medications such as those listed in the Patient Information Leaflet. Please refer to the Patient Information Leaflet for further warnings, precautions, side effects and instructions for use for this product.
Cetirizine Dihydrochloride and Pseudoephedrine Hydrochloride.
https://www.hpra.ie/img/uploaded/swedocuments/Licence PA0891-008-001 30032021094400.pdf
|Dimensions||120 × 120 × 70 mm|
Ucb (pharma ireland ltd)
There are no reviews yet.